contact@welcomeurope.com
+33(0)1 42 54 60 64
Login
Logo Welcomeurope

EU4HEALTH – EU4H HERA Action Grants 2025 – 2025

The "EU for Health" program (EU4health) is the successor to the 3rd EU Health Program. It aims to improve health in the European Union, respond to the COVID-19 health crisis and make healthcare systems more resilient.

2025-12-04
30 million euros
Close

Call synthesis

Call reference EU4H-2025-HERA-PJ
Programme EU4 HEALTH
Institution European Commission
Sectors Health Research & Innovation Technology & Digital
Beneficiaries Large company (> 250 employees) Research centre & university Smes & Start-Ups (< 249 Employees)

Content reserved for subscribers

Call reference

EU4H-2025-HERA-PJ



Register for free to access the content

Free access to all information

Priorities and funded actions

Objectives

  • To improve the Union’s readiness to respond to intentional health threats, by supporting the development of medical countermeasures to biological, chemical and radio-nuclear agents
  • To support advanced research on threat-agnostic medical countermeasures against CBRN agents and platform approaches to treat injuries from CBRN agents
  • To enhance disease detection, reduce misdiagnoses, and improve patient outcomes
  • To advance early detection of VBDs through the development of novel diagnostic tests
  • To increase the accuracy and specificity of existing diagnostic assays to better identify VBD pathogens

Priorities

  • Priority 1 : to develop vaccines and therapeutics against biological, chemical and radio-nuclear threats
  • Priority 2 : to develop reusable respiratory personal protective equipment (PPE) and protection suits
  • Priority 3 : detection and diagnosis

Among financed actions

  • Advanced research and development (‘R&D’)
  • Involvment of end users and security practitioners to bring the research products closer to market readiness
  • Research into market readiness, tech and entrepreneurial skills development
  • Late-stage development of medical devices, improvement of existing products

Eligibility

  • Be a legal person
  • Be a public or private entity
  • Be established in one of the eligible countries:
    • EU Member States (including overseas countries and territories)
    • Non-EU states: listed EEA countries and countries associated to the EU4Health Programme (Click here)
  • Proposals can be submitted either by a single applicant or a consortium (no minimum requirement).

Additional information

  • Initial duration of the action:
    • EU4H-2025-HERA-PJ-1-a : between 24 and 48 months
    • EU4H-2025-HERA-PJ-1-b : 24 months. Projects of longer duration (up to a maximum of 48 months) are possible, if duly justified
    • EU4H-2025-HERA-PJ-1-c : 24 months. Projects of longer duration (up to a maximum of 48 months) are possible, if duly justified
    • EU4H-2025-HERA-PJ-2 : between 36 and 48 months
  • Contact: HADEA-HP-CALLS@ec month.europa.eu

Useful

Financement
  • Total budget of the call: 30 million euros
  • Budget per topic:
    • EU4H-2025-HERA-PJ-1-a : 18 million euros
    • EU4H-2025-HERA-PJ-1-b : 1 million euros
    • EU4H-2025-HERA-PJ-1-c : 1 million euros
    • EU4H-2025-HERA-PJ-2 : 10 million euros
  • Amount of the grant per topic :
    • EU4H-2025-HERA-PJ-1-a : between 5.5 million and 9 million euros
    • EU4H-2025-HERA-PJ-1-b : 1 million euros
    • EU4H-2025-HERA-PJ-1-c : 1 million euros
    • EU4H-2025-HERA-PJ-2 : between 3.3 and 5 million euros
  • Funding rate: 60% of the total eligible costs (80% for projects project of exceptional utility)